CIK 0000899460 · Large accelerated filer
MANNKIND CORP
Sign in to watch- Ticker
- MNKD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133607736
- Phone
- 818-661-5000
- Business address
- 1 CASPER STREET, DANBURY, CT, 06810
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $256,334
- in 2 filings, $256K under 10b5-1 plans
Net −$256,334. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-15 | Thomson David EVP Genl Counsel & Secretary | Shares withheld for taxes 10b5-1 | −30,361 | $3.85 | $117K | 849,185 |
| 2025-07-15 | Sabella Lauren M EVP Operations | Shares withheld for taxes | −11,896 | $3.85 | $46K | 349,841 |
| 2025-07-15 | Prentiss Christopher B Chief Financial Officer | Shares withheld for taxes | −11,540 | $3.85 | $44K | 343,854 |
| 2025-06-23 | Marasco Dominic Pres, Endocrine Business Unit | Grant or award · Performance Restricted Stock Unit | +1,000,000 | 1,000,000 | ||
| 2025-06-10 | Binder Steven B. Director | Sale 10b5-1 | −64,085 | $4.00 | $256K | 925,258 |
| 2025-05-27 | BLANK BURKHARD EVP Chief Medical Officer | Shares withheld for taxes | −15,630 | $4.12 | $64K | 465,124 |
| 2025-05-20 | Binder Steven B. Director | Sale 10b5-1 | −12,078 | $4.40 | $53K | 989,343 |
| 2025-05-20 | Thomson David EVP Genl Counsel & Secretary | Sale 10b5-1 | −2,345 | $4.41 | $10K | 879,546 |
| 2025-05-19 | Tross Stuart A Chief People & Workpl Officer | Shares withheld for taxes | −6,147 | $4.37 | $27K | 1,090,427 |
| 2025-05-19 | Castagna Michael Chief Executive Officer | Shares withheld for taxes | −26,114 | $4.37 | $114K | 2,612,934 |
| 2025-05-19 | Binder Steven B. Director | Shares withheld for taxes 10b5-1 | −5,190 | $4.37 | $23K | 1,001,421 |
| 2025-05-19 | Thomson David EVP Genl Counsel & Secretary | Shares withheld for taxes 10b5-1 | −9,536 | $4.37 | $42K | 881,891 |
| 2025-05-14 | Castagna Michael Chief Executive Officer | Grant or award | +27,000 | $4.56 | $123K | 2,639,048 |
| 2025-05-14 | Marasco Dominic Pres, Endocrine Business Unit | Grant or award | +59,500 | 311,500 | ||
| 2025-05-14 | Marasco Dominic Pres, Endocrine Business Unit | Grant or award | +21,929 | $4.56 | $100K | 333,429 |
| 2025-05-14 | Marasco Dominic Pres, Endocrine Business Unit | Grant or award · Performance Restricted Stock Unit | +72,500 | 72,500 | ||
| 2025-05-14 | HOOPER ANTHONY C Director | Grant or award | +25,000 | $4.56 | $114K | 201,153 |
| 2025-05-14 | HOOPER ANTHONY C Director | Grant or award · Restricted Stock Unit | +52,854 | 52,854 | ||
| 2025-05-14 | HOOPER ANTHONY C Director | Grant or award · Restricted Stock Unit | +10,571 | 10,571 | ||
| 2025-05-14 | Shannon James Samuel Director | Grant or award · Restricted Stock Unit | +52,854 | 52,854 |
Page 7 of 11 · 210 trades